The rise of health-related social media has been phenomenal. It has been estimated that there are over 2.5 billion patient posts from 50 million healthcare users. Health-related social media is increasingly recognized as a potentially important source of evidence. Studies are already being undertaken that aim to directly monitor drug safety and provide evidence of the opinions and unmet needs of large numbers of real patients.
The research field is embryonic, and as in any new field the subject is often viewed with both skepticism and enthusiasm from the pharmaceutical industry. Additionally, there are also important and complex ethical dimensions that should not be overlooked.
This webinar will address:
- The complexities of converting social media into actionable evidence
- The types of information this data source can reveal
- Some of the challenges and ethical considerations of using social media
- Application of social media data through case studies, including breast cancer, cluster headaches, multiple sclerosis, and surgical infections.